BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 7515639)

  • 1. Topical treatment of pityriasis rubra pilaris with calcipotriol.
    Van de Kerkhof PC; Steijlen PM
    Br J Dermatol; 1994 May; 130(5):675-8. PubMed ID: 7515639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [How I treat...pityriasis rubra pilaris].
    Fraiture AL; Braham C; Piérard-Franchimont C; Piérard GE
    Rev Med Liege; 2002 Jun; 57(6):363-5. PubMed ID: 12180027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical improvement of pityriasis rubra pilaris with efalizumab in a pediatric patient.
    Gómez M; Ruelas ME; Welsh O; Arcaute HD; Ocampo-Candiani J
    J Drugs Dermatol; 2007 Mar; 6(3):337-9. PubMed ID: 17373198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of juvenile circumscribed pityriasis rubra pilaris to topical tazarotene treatment.
    Karimian-Teherani D; Parissa M; Tanew A
    Pediatr Dermatol; 2008; 25(1):125-6. PubMed ID: 18304175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate treatment in a case of juvenile pityriasis rubra pilaris.
    Boyd AH; Polcari IC
    Pediatr Dermatol; 2018 Jan; 35(1):e62-e63. PubMed ID: 29044698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial pityriasis rubra pilaris.
    Vanderhooft SL; Francis JS; Holbrook KA; Dale BA; Fleckman P
    Arch Dermatol; 1995 Apr; 131(4):448-53. PubMed ID: 7726588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pityriasis rubra pilaris: a review of diagnosis and treatment.
    Cohen PR; Prystowsky JH
    J Am Acad Dermatol; 1989 May; 20(5 Pt 1):801-7. PubMed ID: 2654219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pityriasis rubra pilaris and HIV infection.
    Blauvelt A; Nahass GT; Pardo RJ; Kerdel FA
    J Am Acad Dermatol; 1991 May; 24(5 Pt 1):703-5. PubMed ID: 1869640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical treatment with the vitamin D3 analogue MC903 improves pityriasis rubra pilaris: clinical and immunohistochemical observations.
    van de Kerkhof PC; de Jong EM
    Br J Dermatol; 1991 Sep; 125(3):293-4. PubMed ID: 1911337
    [No Abstract]   [Full Text] [Related]  

  • 10. Pityriasis rubra pilaris, type 1.
    Booth AV; Ma L
    Dermatol Online J; 2005 Dec; 11(4):9. PubMed ID: 16403381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pityriasis rubra pilaris: a clinico-pathological and therapeutic study with special reference to histochemistry, autoradiography, and electron microscopy.
    Braun-Falco O; Ryckmanns F; Schmoeckel C; Landthaler M
    Arch Dermatol Res; 1983; 275(5):287-95. PubMed ID: 6660901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pityriasis rubra pilaris.
    White KL
    Dermatol Online J; 2003 Oct; 9(4):6. PubMed ID: 14594579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of topical calcipotriene/calcipotriol in conditions other than plaque-type psoriasis.
    Thiers BH
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S69-71. PubMed ID: 9344189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Ixekizumab Treatment for Patients With Pityriasis Rubra Pilaris: A Single-Arm Trial.
    Haynes D; Strunck JL; Topham CA; Ortega-Loayza AG; Kent G; Cassidy PB; Hu R; Choate K; Wang Z; Liu Y; Greiling TM
    JAMA Dermatol; 2020 Jun; 156(6):668-675. PubMed ID: 32293641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Marking disorders of keratinization by means of lectins. II. Keratosis pilaris, lichen spinulosus, porokeratosis, lichen striatus and pityriasis rubra pilaris].
    Martinez Ojeda L; Ramirez Bosca A; Valcuende Cavero F; Massmanian A; Castells Rodellas A
    Med Cutan Ibero Lat Am; 1988; 16(3):183-6. PubMed ID: 2462142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exacerbation of pityriasis rubra pilaris under efalizumab therapy.
    Klein A; Szeimies RM; Landthaler M; Karrer S
    Dermatology; 2007; 215(1):72-5. PubMed ID: 17587845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of resistant pityriasis ribra pilaris responsive to combination acitrentin and ustekinumab.
    Cook E; Tran KW; Kollipara S; Tarbox M; Akin R
    Dermatol Online J; 2020 Mar; 26(3):. PubMed ID: 32609453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acral pityriasis rubra pilaris.
    Sander M; Sander M
    CMAJ; 2020 Feb; 192(5):E118. PubMed ID: 32015081
    [No Abstract]   [Full Text] [Related]  

  • 19. Adalimumab for the treatment of pityriasis rubra pilaris: a case report.
    Wassef C; Lombardi A; Rao BK
    Cutis; 2012 Nov; 90(5):244-7. PubMed ID: 23270195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histologic criteria for the diagnosis of pityriasis rubra pilaris.
    Soeprono FF
    Am J Dermatopathol; 1986 Aug; 8(4):277-83. PubMed ID: 3766917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.